8月18日中银创新医疗混合A净值增长1.15%，今年来累计上涨92.48%

Core Insights - The latest net value of Zhongyin Innovation Medical Mixed A (007718) is 2.3161 yuan, reflecting a growth of 1.15% [1] - The fund has shown a one-month return of 6.31%, a six-month return of 87.27%, and a year-to-date return of 92.48%, ranking 2207 out of 3424, 17 out of 3319, and 21 out of 3301 respectively [1] Fund Holdings - The top ten stock holdings of Zhongyin Innovation Medical Mixed A account for a total of 62.83%, with significant positions in companies such as: - Innovent Biologics (8.33%) - Kelun-Biotech (8.15%) - Heng Rui Medicine (8.08%) - CanSino Biologics (8.07%) - New Horizon Health (6.13%) - Baillie Gifford (5.99%) - BeiGene (5.97%) - Hansoh Pharmaceutical (4.15%) - Rongchang Biologics (4.05%) - CanSino Biologics-B (3.91%) [1] Fund Manager Background - Zheng Ning, the fund manager of Zhongyin Innovation Medical Mixed A, has a master's degree and has previously held positions at Taikang Asset Management and Zhonggeng Fund Management, focusing on stock research in the healthcare sector [2] - Zheng Ning has been managing the fund since July 1, 2022, and has also taken on managerial roles for other healthcare-related funds [2]